You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Biomarker

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

PET Amyloid Classification Technology

Unknown status
  • Mild Cognitive Impairment
  • +2 more
  • Salt Lake City, Utah
    Center for Alzheimer's Care, Imaging & Research
Jan 24, 2020

Invasive Bladder Cancer Stage IV Trial in Beijing (PD-1 Knockout T Cells, Cyclophosphamide, IL-2)

Withdrawn
  • Invasive Bladder Cancer Stage IV
  • PD-1 Knockout T Cells
  • +2 more
  • Beijing, Beijing, China
    Department of Urology Peking University First Hospital
Mar 4, 2019

Cardiac Arrest Trial in Korea, Republic of (Neu2000KWL High-dose group, Neu2000KWL Low-dose group, Placebo)

Unknown status
  • Cardiac Arrest
  • Neu2000KWL High-dose group
  • +2 more
  • Daegu, Korea, Korea, Republic of
  • +5 more
Mar 5, 2019

Adenocarcinoma of the Prostate, Stage II Prostate Cancer, Stage III Prostate Cancer Trial in Seattle, Tacoma (drug, other,

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • abiraterone acetate
  • +5 more
  • Seattle, Washington
  • +1 more
May 3, 2017

Neutropenic Fever/Infection With Acute or Chronic Leukemias

Completed
  • Leukemia, Lymphocytic
  • Leukemia, Myeloid
    • Stanford, California
      Stanford University School of Medicine
    Dec 23, 2016

    Breast Cancer Trial in Worldwide (Standard taxane therapy, capecitabine [Xeloda], trastuzumab [Herceptin])

    Completed
    Has Results
    • Breast Cancer
    • Standard taxane therapy
    • +2 more
    • Camperdown, New South Wales, Australia
    • +12 more
    Feb 28, 2018

    Aicardi-Goutières Syndrome (AGS) Trial in Paris (Reverse transcriptase inhibitors: Zidovudine, Lamivudine, Abacavir)

    Completed
    • Aicardi-Goutières Syndrome (AGS)
    • Reverse transcriptase inhibitors: Zidovudine, Lamivudine, Abacavir
    • Paris, France
      Hôpital Necker - Enfants Malades
    Mar 14, 2019

    Ischemia: Xanthine, Hypoxanthine and Inosine Levels During

    Completed
    • Identify the Presence of a Marker of Ischemia/Hypoperfusion of the Brain Via Peripheral Blood
    • Ischemia/Hypoperfusion of Brain
      • Richmond, Virginia
        Virginia Commonwealth University
      Jul 27, 2018

      CTCs and ctDNA in Blood and Plasma Samples From Metastatic

      Terminated
      • Hormone-Resistant Prostate Cancer
      • Metastatic Prostate Carcinoma
      • Cytology Specimen Collection Procedure
      • Laboratory Biomarker Analysis
      • Los Angeles, California
        USC Norris Comprehensive Cancer Center
      Apr 13, 2017

      Magnetic Resonance Imaging and Spectroscopy Biomarkers of

      Completed
      • Hypoxic Ischemic Encephalopathy
        • Zürich, Switzerland
          University Children's Hospital Zurich, MRI Center
        Sep 24, 2019

        Non Small Cell Lung Cancer Trial in Chongqing (EGFR-TKIs, thoracic radiotherapy)

        Terminated
        • Non Small Cell Lung Cancer
        • Chongqing, China
          Xinqiao Hospital of Chongqing
        Dec 19, 2018

        Multicenter AIDS Cohort Study (MACS)

        Unknown status
        • HIV Infections
          • Los Angeles, California
          • +3 more
          Jul 17, 2019

          Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma Trial in Boston (dinaciclib, pharmacological study, laboratory

          Terminated
          Has Results
          • Stage IIIB Melanoma
          • +2 more
          • Boston, Massachusetts
            Dana-Farber Cancer Institute
          Mar 3, 2017

          Hepatocellular Carcinoma With 5-Hydroxymethylcytosine Test

          Unknown status
          • Hepatocellular Carcinoma
          • 5hmC profile in plasma cell-free DNA after liver resection
          • Shanghai, Shanghai, China
            Zhongshan Hospital
          Apr 9, 2018

          Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer Trial in

          Terminated
          Has Results
          • Estrogen Receptor-positive Breast Cancer
          • +5 more
          • Seattle, Washington
            Fred Hutchinson Cancer Research Center/University of Washington
          Jun 9, 2017

          Chronic Renal Insufficiency, Diabete Mellitus, CHF Trial in Princeton (GE-145)

          Completed
          Has Results
          • Chronic Renal Insufficiency
          • +2 more
          • Princeton, New Jersey
            GE Healthcare
          Aug 1, 2018

          HER2/Neu Positive, Recurrent Breast Carcinoma, Stage IIIB Breast Cancer Trial in Seattle (Laboratory Biomarker Analysis,

          Completed
          • HER2/Neu Positive
          • +4 more
          • Laboratory Biomarker Analysis
          • +2 more
          • Seattle, Washington
            Fred Hutch/University of Washington Cancer Consortium
          May 19, 2017

          Heart Failure Trial in Worldwide (QGC001, Placebo)

          Terminated
          • Heart Failure
          • Frýdek-Místek, Czechia
          • +22 more
          Oct 11, 2018

          Prostate Cancer Trial in Los Angeles (dietary supplement, other, procedure)

          Completed
          • Prostate Cancer
          • Fish Oil
          • +7 more
          • Los Angeles, California
          • +1 more
          May 3, 2019

          Feasibility of Isolating P16 Expression

          Completed
          • Childhood Cancer
            • Memphis, Tennessee
              St. Jude Children's Research Hospital
            May 2, 2019

            Appendicitis Trial in Leeds (Blowing into the mouthpiece)

            Completed
            • Appendicitis
            • Blowing into the mouthpiece
            • Leeds, United Kingdom
              Leeds Teaching Hospitals NHS Trust
            Nov 4, 2019

            Child Development Trial in São Paulo (Home visiting Program for Young Pregnant Women)

            Unknown status
            • Child Development
            • Home visiting Program for Young Pregnant Women
            • São Paulo, Brazil
              Faculdade de Medicina da Universidade de São Paulo
            Oct 11, 2018

            Medullary Thyroid Carcinoma Trial run by the NCI (Bortezomib, Vandetanib)

            Terminated
            Has Results
            • Medullary Thyroid Carcinoma
            • Bethesda, Maryland
              National Institutes of Health Clinical Center, 9000 Rockville Pi
            Nov 5, 2018

            Functional Pancreatic Neuroendocrine Tumor, Malignant Somatostatinoma, Merkel Cell Carcinoma Trial (Capecitabine, Temozolomide,

            Withdrawn
            • Functional Pancreatic Neuroendocrine Tumor
            • +28 more
            • (no location specified)
            Sep 26, 2017

            Type 2 Diabetes Trial (drug, other, biological)

            Completed
            Has Results
            • Type 2 Diabetes Mellitus
            • Ertugliflozin 5 mg
            • +6 more
            • (no location specified)
            Aug 9, 2018